Cardiomyopathy in obesity, insulin resistance and diabetes
Why the study?
Most clinical studies show no beneficial effect of anti-diabetic agents and statins on outcomes in heart failure patients without atherosclerotic diseases, highlighting the need to identify underlying mechanisms and early interventions for diabetic cardiomyopathy.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Suggests PPAR alpha modulation as a research target in diabetic cardiomyopathy; leaves open clinical validation of lipotoxicity therapies.
Structured PICO
P
Population
Patients with obesity, insulin resistance, and diabetes at risk for or with diabetic cardiomyopathy
This review highlights the role of cardiac lipotoxicity and dysregulated fatty acid metabolism in the pathogenesis of diabetic cardiomyopathy, suggesting PPAR alpha as a potential therapeutic target.
Cite This Study
Nakamura et al. (2019) studied this question.